Antibody
Investigational
Unknown
Unknown
Hodgkin Disease; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Squamous Cell; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute
Killer cell immunoglobulin-like receptor 2DL1 inhibitor
|